These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 33844152

  • 1. Circadian Rhythm Sleep-Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease.
    Steele TA, St Louis EK, Videnovic A, Auger RR.
    Neurotherapeutics; 2021 Jan; 18(1):53-74. PubMed ID: 33844152
    [Abstract] [Full Text] [Related]

  • 2. Tasimelteon for treating non-24-h sleep-wake rhythm disorder.
    Nishimon S, Nishimon M, Nishino S.
    Expert Opin Pharmacother; 2019 Jun; 20(9):1065-1073. PubMed ID: 30990759
    [Abstract] [Full Text] [Related]

  • 3. Circadian Rhythm Sleep-Wake Disorders.
    Pavlova M.
    Continuum (Minneap Minn); 2017 Aug; 23(4, Sleep Neurology):1051-1063. PubMed ID: 28777176
    [Abstract] [Full Text] [Related]

  • 4. Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.
    Williams WP, McLin DE, Dressman MA, Neubauer DN.
    Pharmacotherapy; 2016 Sep; 36(9):1028-41. PubMed ID: 27500861
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind.
    Emens JS, Eastman CI.
    Drugs; 2017 Apr; 77(6):637-650. PubMed ID: 28229310
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients.
    Stahl SM.
    CNS Spectr; 2014 Dec; 19(6):475-8. PubMed ID: 25422900
    [Abstract] [Full Text] [Related]

  • 7. [Diagnosis and comorbidities of Circadian Rhythm Sleep Disorders].
    Ruppert E, Kilic-Huck U, et le Groupe consensus chronobiologie et sommeil de la Société française de recherche et médecine du sommeil (SFRMS).
    Presse Med; 2018 Dec; 47(11-12 Pt 1):969-976. PubMed ID: 30391268
    [Abstract] [Full Text] [Related]

  • 8. Workshop report. Circadian rhythm sleep-wake disorders: gaps and opportunities.
    Duffy JF, Abbott SM, Burgess HJ, Crowley SJ, Emens JS, Epstein LJ, Gamble KL, Hasler BP, Kristo DA, Malkani RG, Rahman SA, Thomas SJ, Wyatt JK, Zee PC, Klerman EB.
    Sleep; 2021 May 14; 44(5):. PubMed ID: 33582815
    [Abstract] [Full Text] [Related]

  • 9. Advances in the pharmacological management of non-24-h sleep-wake disorder.
    Nishimon S, Nishino N, Nishino S.
    Expert Opin Pharmacother; 2021 Jun 14; 22(8):1039-1049. PubMed ID: 33618599
    [Abstract] [Full Text] [Related]

  • 10. Clinical neurophysiology of circadian rhythm sleep-wake disorders.
    Saeed Y, Zee PC, Abbott SM.
    Handb Clin Neurol; 2019 Jun 14; 161():369-380. PubMed ID: 31307614
    [Abstract] [Full Text] [Related]

  • 11. Therapeutics for Circadian Rhythm Sleep Disorders.
    Dodson ER, Zee PC.
    Sleep Med Clin; 2010 Dec 14; 5(4):701-715. PubMed ID: 21243069
    [Abstract] [Full Text] [Related]

  • 12. Tasimelteon: first global approval.
    Dhillon S, Clarke M.
    Drugs; 2014 Mar 14; 74(4):505-11. PubMed ID: 24610704
    [Abstract] [Full Text] [Related]

  • 13. Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.
    Zisapel N.
    CNS Drugs; 2001 Mar 14; 15(4):311-28. PubMed ID: 11463135
    [Abstract] [Full Text] [Related]

  • 14. Circadian rhythm abnormalities.
    Zee PC, Attarian H, Videnovic A.
    Continuum (Minneap Minn); 2013 Feb 14; 19(1 Sleep Disorders):132-47. PubMed ID: 23385698
    [Abstract] [Full Text] [Related]

  • 15. Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder.
    Johnsa JD, Neville MW.
    Ann Pharmacother; 2014 Dec 14; 48(12):1636-41. PubMed ID: 25204464
    [Abstract] [Full Text] [Related]

  • 16. Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials.
    Lockley SW, Dressman MA, Licamele L, Xiao C, Fisher DM, Flynn-Evans EE, Hull JT, Torres R, Lavedan C, Polymeropoulos MH.
    Lancet; 2015 Oct 31; 386(10005):1754-64. PubMed ID: 26466871
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Circadian Rhythm Sleep-Wake Disorders.
    Sun SY, Chen GH.
    Curr Neuropharmacol; 2022 Oct 31; 20(6):1022-1034. PubMed ID: 34493186
    [Abstract] [Full Text] [Related]

  • 18. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R.
    Curr Opin Investig Drugs; 2009 Jul 31; 10(7):691-701. PubMed ID: 19579175
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.